Cargando…
Superior efficacy of St John's wort extract WS(® )5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]
BACKGROUND: The aim of the current study was to assess the antidepressant efficacy and safety of Hypericum perforatum (St. John's wort) extract WS(® )5570 at doses of 600 mg/day in a single dose and 1200 mg/day in two doses. METHODS: The participants in this double-blind, randomized, placebo-co...
Autores principales: | Kasper, Siegfried, Anghelescu, Ion-George, Szegedi, Armin, Dienel, Angelika, Kieser, Meinhard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538611/ https://www.ncbi.nlm.nih.gov/pubmed/16796730 http://dx.doi.org/10.1186/1741-7015-4-14 |
Ejemplares similares
-
Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis
por: Seifritz, Erich, et al.
Publicado: (2016) -
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
por: Möller, Hans-Jürgen, et al.
Publicado: (2017) -
St. John’s Wort-Induced Supraventricular Tachycardia
por: Fisher, Kristy A, et al.
Publicado: (2021) -
Are the St John’s wort Hyp-1 superstructures different?
por: Lovelace, Jeffrey J., et al.
Publicado: (2021) -
St. John's Wort usage in treating of perinatal depression
por: Zepeda, Rossana C., et al.
Publicado: (2023)